Generic Pharmaceuticals: Key findings, summary and notes

Oecd

No 107, OECD Roundtables on Competition Policy Papers from OECD Publishing

Abstract: The OECD Competition Committee held a roundtable discussion on Generic Pharmaceuticals in October 2009. This document includes an executive summary and the documents from the meeting: an analytical note by the staff of the United States Federal Trade Commission, written submissions from Canada, the Czech Republic, the European Commission, India, Indonesia, Ireland, Italy, Japan, Korea, Norway, the Russian Federation, South Africa, Spain, Sweden, the United Kingdom, the United States, and BIAC, as well as an aide-memoire.

Date: 2010-10-05
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1787/fb859097-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:dafaac:107-en

Access Statistics for this paper

More papers in OECD Roundtables on Competition Policy Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().